Joe Lonsdale Backs US Startup to Boost Domestic Monkey Supply for Drug Testing
What happened
Joe Lonsdale is supporting Safer Human Medicine, a US startup planning a large-scale breeding facility. The company intends to produce 30,000 macaques over approximately 20 years to expand domestic production. This effort aims to reduce American laboratories' dependence on imported animals for pharmaceutical research and testing. The startup is responding to restrictions placed on animal imports due to China's export ban.
From techradar.com
Why it matters
The demand for animal test subjects is increasing because artificial intelligence is enabling researchers to develop potential medicines more rapidly. Macaques, which are commonly used in medical experiments, have become considerably more expensive, with reported prices rising from about $3,000 in 2019 to over $20,000 today. The startup's plan addresses this rising cost and supply restriction.
From techradar.com
Who's involved
- Joe LonsdaleAmerican entrepreneur and co-founder of Palantir Technologies
- Palantir TechnologiesAmerican software and services company co-founded by Joe Lonsdale
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- ChinaSpeculative
China's export ban on research animals could restrict the supply of animals, potentially impacting Chinese exporters.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.Keep exploring
The entities involved
-
Joe Lonsdale
American entrepreneur and venture capitalist
Nothing else this week.
-
China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China